Syndax Pharmaceuticals Grants Stock Options to New Employee Under 2023 Inducement Plan
Syndax Pharmaceuticals Inc. has granted stock options to a new employee under its 2023 Inducement Plan, allowing the purchase of up to 15,500 shares. The options vest over four years, with 25% vesting after one year and the rest monthly over three years, contingent on continued employment. This announcement was originally published by Syndax Pharmaceuticals via GlobeNewswire.
Syndax Pharmaceuticals Inc. has granted inducement awards to a new employee, allowing for the purchase of up to 15,500 shares of common stock under the company’s 2023 Inducement Plan. The stock options will vest over four years, with 25% vesting after one year and the remainder vesting in equal monthly installments over the following three years, contingent on continued employment. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Syndax Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9595696-en) on December 03, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)
